The anti-Candida haemulonii activity and bioactive metabolites of Streptomyces anandii NC-SA6
Frontiers in Cellular and Infection Microbiology · 30.06.2026 · 16
DOI: 10.3389/fcimb.2026.1851966 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 30.06.2026. Verfasst von Chunxi Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China. Hauptthemen laut MEDLINE: Streptomyces, Antifungal Agents, Candida. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The rapid advancement of multi-omics strategies has profoundly facilitated the in-depth exploration of microbial physiological characteristics, accelerated the discovery of novel bioactive secondary metabolites, and promoted the mechanistic elucidation of their biological functions. As a dominant genus within the phylum Actinomycetota, Streptomyces is widely recognized for its remarkable capacity to synthesize a diverse spectrum of clinically applicable antibiotics. Candida haemulonii , an emerging opportunistic fungal pathogen, has emerged as a typical multidrug-resistant species closely associated with outbreaks of nosocomial infections, posing a severe threat to clinical antifungal therapy.
Methods
In this study, a novel strain designated as Streptomyces anandii NC-SA6 was isolated and systematically identified via gradient dilution method, multilocus sequence analysis (MLSA), coupled with comprehensive physiological and biochemical characterization assays. The optimal fermentation condition was optimized by controling a single variable method and measuring the diameter of the inhibition zone. The antimicrobial spectrum was tested against a panel of pathogenic strains, and the MIC value was measured by using broth microdilution. Finally, antifungal compounds were analyzed by combnining genome and metabolomic.
Results
We identified a strain with a spectrum antimicrobial activity against human pathogenic Candida species and Gram-positive bacteria. The optimal fermentation conditions are 4-day fermentation broth in No. 6 medium, and the MIC values of S. anandii NC-SA6 fermentation broth for Candida auris BJCA001 and Candida haemulonii 190070, the MIC50 values were 36.8 mg/ml and 18.4 mg/ml, respectively. Whole-genome sequencing analysis revealed the presence of 20 biosynthetic gene clusters (BGCs) responsible for secondary metabolite biosynthesis. Untargeted metabolomic analysis identified a total of 1703 metabolites. Functional annotation demonstrated that 43.5% of these metabolites were characterized bioactive compounds, including antimicrobial agents, antifungal agents, antitumor inhibitors, and other pharmaceutical molecules; the remaining 56.5% were uncharacterized metabolites, indicating the existence of potential secondary metabolites.
Discussion
Collectively, this integrated multi-omics study identified S. anandii NC-SA6 as a promising microbial resource for mining antifungal metabolites targeting multidrug-resistant C. haemulonii , highlighting its tremendous potential for the discovery and developmental research of novel antifungal agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Clinical Medicine, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
- Jiangxi Key Laboratory for Excavation and Utilization of Agricultural Microorganisms, Jiangxi Agricultural University, Nanchang, China.
Zitieren
APA
Yang, C., Cui, C., Chen, Y., Deng, F., & Peng, Z. (2026). The anti-Candida haemulonii activity and bioactive metabolites of Streptomyces anandii NC-SA6. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1851966
Vancouver
Yang C, Cui C, Chen Y, Deng F, Peng Z. The anti-Candida haemulonii activity and bioactive metabolites of Streptomyces anandii NC-SA6. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1851966
BibTeX
@article{Yang2026,
author = {Yang, Chunxi and Cui, Chaoyu and Chen, Yanru and Deng, Fengyi and Peng, Zimei},
title = {The anti-Candida haemulonii activity and bioactive metabolites of Streptomyces anandii NC-SA6},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1851966}
}
EUVIMED